financetom
Business
financetom
/
Business
/
Intel defeats shareholder lawsuit over foundry losses, $32 billion plunge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intel defeats shareholder lawsuit over foundry losses, $32 billion plunge
Mar 5, 2025 9:25 AM

(Reuters) - Intel ( INTC ) won the dismissal of a shareholder lawsuit accusing the chipmaker of fraudulently concealing problems in its foundry business, leading to job cuts and a dividend suspension that wiped out more than $32 billion of market value in one day.

In a decision made public on Tuesday, U.S. District Judge Trina Thompson in San Francisco rejected claims that Intel ( INTC ) took too long to reveal a $7 billion fiscal 2023 operating loss linked to its business of making chips for outside customers.

Intel ( INTC ) did not disclose the loss until last April, when it made changes to how it reported financial results.

But the judge said shareholders incorrectly attributed the $7 billion loss to the Intel Foundry Services business unit, and were not misled into believing the unit's reported results "included results for the entire Internal Foundry Model."

Thompson also said statements last March by former Chief Executive Patrick Gelsinger that Intel ( INTC ) was enjoying "significant traction" and "growing demand for our foundry offering" were not misleading because they concerned specific customers rather than overall revenue, which was falling.

Lawyers for the shareholders did not immediately respond on Wednesday to a request for comment. Intel ( INTC ) declined to comment. Thompson said the plaintiffs may file an amended complaint.

The lawsuit accused Intel ( INTC ) of inflating its stock price from January 25 to August 1, 2024, when Intel ( INTC ) posted a $1.61 billion quarterly loss and said it would lay off more than 15,000 people and suspend its dividend to help save $10 billion in 2025.

Intel's ( INTC ) share price fell 26% the next day, resulting in the $32 billion loss of market value.

The Santa Clara, California-based company has struggled to fend off competition from rival chipmakers and benefit from growth in artificial intelligence.

Its rivals include Nvidia ( NVDA ), Advanced Micro Devices ( AMD ), Samsung Electronics ( SSNLF ) and Taiwan's TSMC. Intel ( INTC ) ousted Gelsinger in December.

The case is In re Intel Corp Securities Litigation, U.S. District Court, Northern District of California, No. 24-02683.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bicara Therapeutics' Q3 Loss Narrows
Bicara Therapeutics' Q3 Loss Narrows
Nov 12, 2024
09:06 AM EST, 11/12/2024 (MT Newswires) -- Bicara Therapeutics ( BCAX ) reported a Q3 net loss Tuesday of $1.60 per share, narrowing from a loss of $38.23 a year earlier. A single analyst polled by Capital IQ expected a loss of $0.43 per share. As of Sept. 30, the company said it had $520.8 million as cash and cash...
Disc Medicine's Q3 Net Loss Widens
Disc Medicine's Q3 Net Loss Widens
Nov 12, 2024
09:08 AM EST, 11/12/2024 (MT Newswires) -- Disc Medicine ( IRON ) reported a Q3 loss Tuesday of $0.89 per share, wider than a loss of $0.58 a year earlier. Analysts polled by Capital IQ expected a loss of $0.99. As expected, no revenue for the quarter ended Sept. 30 was reported. As of Sept. 30, the company had $487.4...
Greenlane Renewables Inks $6.5 Million Landfill Gas-to-RNG System Contract
Greenlane Renewables Inks $6.5 Million Landfill Gas-to-RNG System Contract
Nov 12, 2024
09:07 AM EST, 11/12/2024 (MT Newswires) -- Greenlane Renewables ( GRNWF ) on Tuesday said it has secured a $6.5 million contract from an unnamed customer to provide a new system for upgrading biogas produced at a landfill in Canada into pipeline-quality renewable natural gas (RNG). We're seeing traction on the further build out of RNG-producing facilities in Canada and...
ProKidney Q3 Net Loss Narrows; Cash on Hand to Fund Operations Until 2027
ProKidney Q3 Net Loss Narrows; Cash on Hand to Fund Operations Until 2027
Nov 12, 2024
09:02 AM EST, 11/12/2024 (MT Newswires) -- ProKidney ( PROK ) reported a Q3 net loss Tuesday of $0.14 per diluted share, narrowing from a loss of $0.18 a year earlier. Two analysts polled by Capital IQ expected a loss of $0.35. The company reported no revenue. Cash and cash equivalents at the end of the quarter ended Sept. 30...
Copyright 2023-2026 - www.financetom.com All Rights Reserved